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Abstract
Background
Ghana’s national prevalence survey showed higher than expected tuberculosis (TB) preva-
lence, indicating that many people with TB are not identified and treated. This study aimed
to identify gaps in the TB diagnostic cascade prior to starting treatment.
Methods
A prospective cohort study was conducted in urban and rural health facilities in south-east
Ghana. Consecutive patients routinely identified as needing a TB test were followed up for
two months to find out if sputum was submitted and/or treatment started. The causal effect
of health facility location on submitting sputum was assessed before risk factors were inves-
tigated using logistic regression.
Results
A total of 428 persons (mean age 48 years, 67.3% female) were recruited, 285 (66.6%) from
urban and 143 (33.4%) from rural facilities. Of 410 (96%) individuals followed up, 290
(70.7%) submitted sputum, among which 27 (14.1%) had a positive result and started treat-
ment. Among those who visited an urban facility, 245/267(91.8%) submitted sputum, com-
pared to 45/143 (31.5%) who visited a rural facility. Participants recruited at the urban facility
were far more likely to submit a sputum sample (odds ratio (OR) 24.24, 95%CI 13.84–
42.51). After adjustment for confounding, there was still a strong association between
attending the urban facility and submitting sputum (adjusted OR (aOR) 9.52, 95%CI 3.87–
23.40). Travel distance of >10 km to the laboratory was the strongest predictor of not sub-
mitting sputum (aOR 0.12, 95%CI 0.05–0.33).
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Conclusion
The majority of presumptive TB patients attending a rural health facility did not submit spu-
tum for testing, mainly due to the long travel distance to the laboratory. Bridging this gap in
the diagnostic cascade may improve case detection.
Introduction
Ghana is one of the tuberculosis (TB) and human immunodeficiency virus (HIV) high burden
countries according to the World Health Organization (WHO) [1]. Ghana’s TB case notifica-
tion rate has declined from 56/100,000 in 2014 [2] to 52/100,000 in 2017[3] compared to an
estimated incidence of 152/100,000 based on the 2013 national TB prevalence survey [4]. Gha-
na’s national TB prevalence survey also highlighted weaknesses in the care cascade where of
persons with prolonged cough who visited a health facility, only 25% submitted sputum for
testing [4].
In Ghana, TB diagnosis and treatment is mainly done at government health facilities. Until
recently, sputum smear microscopy was the main diagnostic method, but Xpert MTB/RIF has
now been introduced with 105 GeneXpert machines installed nationwide by 2017 [3]. Most
diagnostic laboratories are located at secondary and tertiary levels of care but not at peripheral
levels such as health centres mostly in rural areas. Therefore, a person with symptoms of TB
might be identified at a health centre but will have to travel themselves to the district hospital
for a sputum test to confirm the diagnosis. This creates an obstacle to diagnosis and treatment
and potential loss within the cascade of TB care.
There is a wealth of literature on health facility contribution to delayed or missed diagnosis
of TB and pre-treatment loss-to-follow up [5–9]; however, most are cross-sectional studies
involving TB patients already on treatment, thus excluding those who never started treatment,
or retrospective reviews of secondary data [10]. To better understand losses from the care cas-
cade, we conducted a prospective observational cohort study to identify where and when
potential TB patients are missed in the diagnostic cascade. We hypothesized that distance to
the laboratory was a key determinant of whether sputum was submitted or not, therefore, per-
sons with symptoms suggestive of TB (presumptive TB patients) were less likely to submit a
sputum if they attended a rural health facility without a laboratory compared to those attend-
ing an urban facility with a co-located laboratory. Our aim was to determine if persons asked
to submit sputum for testing for TB submitted sputum, and whether this was associated with
urban vs. rural location of the facility; also whether they received test results, and if the results
were positive, whether they started TB treatment.
Materials and methods
Study setting
The study was conducted in Ketu South Municipality in the Volta region of Ghana, which
shares boundaries with the Republic of Togo. The municipality has one government hospital
and eight health centres. In 2017, the municipality notified 290 TB cases out of a target of 534
estimated based on the 2013 national TB prevalence survey. In 2018, it notified 172 TB cases
out of a target of 546, indicating a decreased case detection rate from 53.8% in 2017 to 31.5%
in 2018 [11]. There is only one TB diagnostic laboratory in the municipality, located at the
municipal hospital. All other health facilities in the municipality refer patients with symptoms
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of TB to the municipal hospital for testing. The study was thus conducted in the municipal
hospital, and four health centres without co-located TB diagnostic facilities in rural areas
located 10 to 20 km from the municipal hospital. The four health centres were selected based
on high outpatient department (OPD) attendance and to represent the different health demar-
cated sub-municipalities.
Study design
This was a prospective observational cohort study among adults aged�18 years with or with-
out symptoms suggesting TB, self-presenting at the health facility, who were identified rou-
tinely by a health worker as needing TB investigation and given a laboratory request to do a
sputum test or referred to the municipal hospital.
Sampling strategy. We consecutively invited eligible patients from the selected health
facilities from May 2018 until the target study population had been enrolled in February 2019.
Data collection
At enrolment, trained research assistants collected baseline information on socio-demographic
characteristics, symptoms of illness, health histories and date the sputum test was requested,
using a standardised questionnaire. The questionnaire was pretested at the municipal hospital
in a population similar to the study population. Following pretesting, revisions were made to
improve comprehensibility and understanding. Participants were followed up for two months
after the test request, via two-weekly phone calls to find out if sputum had been submitted,
when and where it was submitted and the result of the test; and among those with a positive
test result, to determine whether the patient had started TB treatment. Those without phones
were visited at their homes once monthly for two months. Geographic positioning coordinates
(GPS) of participant households and health facilities attended were collected. Coordinates
were stored separately from participant information to ensure confidentiality. All data were
collected electronically using Open Data Kit (ODK) and uploaded onto a secured server hosted
by the London School of Hygiene & Tropical Medicine.
Sample size
Assuming 49% of participants attending an urban facility would submit sputum [7], we calcu-
lated that a sample size of 414 would provide 80% power to detect a difference of 15% in the
proportion of participants who submitted a sputum in an urban versus a rural facility with
alpha set to 5% and allowing 10% loss to follow up.
Measures and definitions
TB symptoms were defined as the four cardinal symptoms of TB (cough, fever, weight loss and
night sweats) and/or other TB symptoms (chest pain, coughing up blood, tiredness, shortness
of breath and/or lump in neck). Rural and urban residence was defined based on the municipal
health directorate categorization. Socioeconomic status was generated using asset scores which
included 33 items, based on methods used by demographic and health surveys [12]. Partici-
pants’ attitudes of stigma towards people with TB were measured using a tool developed by
Van Rie et al, based on 12 questions measured on a five-point Likert scale, with 1 being lowest
score for stigma and 5 being the highest [13]. The mean score across the 12 questions was cal-
culated and dichotomized to represent high perceived or low perceived stigma. Distance from
a participant’s residence to the TB diagnostic facility was generated from GPS coordinates.
Body mass index (BMI) was categorized according to WHO guidelines [14]. A Karnofsky
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score was estimated as a measure of illness severity [15]. Diabetes and HIV status were defined
based on participant self-report.
Primary outcome. This was the proportion of participants who submitted a sputum
sample.
Data management and statistical analysis
Primary analysis assessed the causal effect of type of health facility attended (urban versus
rural) on the probability of submitting sputum, using logistic regression. Any factor that
changed the odds ratio by approximately 10% in bivariable analysis was considered a potential
confounder and adjusted for in a final multivariable model. Kaplan-Meier analysis was used to
compare the time to submitting sputum between urban and rural facility attendees. Predictive
modelling was employed to assess risk factors associated with submitting sputum using logistic
regression. Variables with likelihood ratio p-value <0.2 in univariable analysis were included
in a multivariable model. Data were analysed using Stata v15 (Stata Corp, College Station TX,
USA).
Ethical considerations
Ethical approval was obtained from the Ghana Health Service Ethics Review Committee and
London School of Hygiene & Tropical Medicine Ethics Committee. Written informed consent
was obtained from literate participants and for those who could not read and write, consent
was documented with a thumbprint in the presence of a literate witness.
Results
A total of 468 persons were approached: of this number 437 (93.4%) were eligible, 428/437
(97.9%) consented and were recruited (285 from urban facility and 143 from rural facilities).
The main reason for non-eligibility was being <18 years (28, 90.3%). Of the 428 recruited, 397
(92.8%) completed follow-up for two months, 13 (3.0%) died at some point in time within the
two-month follow-up period and 17 (4.0%) were lost to follow up (Fig 1).
Baseline characteristics of study participants
Among 428 participants, the mean age was 48 years (standard deviation [SD]18.8) and this
was similar among urban and rural facilities (Table 1). The majority of participants (288,
67.3%) were female and most (237, 55.4%) had attained primary level education. The median
distance between participants’ home and the laboratory was 17.3 km (interquartile range
[IQR]16.7–19.4) for rural facility attendees and 2.6 km (IQR 1.3–10.0) for urban facility
attendees. Most participants attending rural facilities were in the lowest socioeconomic tertile
(58, 40.6%) compared to those attending urban facilities (85, 29.8%) and more than half (255,
59.6%) of study participants had a high perception of TB related stigma.
Cascade of care
Of 410 presumptive TB patients asked to do a sputum test who were followed up, 290 (70.7%)
submitted sputum for the test; 194/290 (66.9%) received a test result; 27/194 (13.9%) had a pos-
itive test result and all 27 started TB treatment (Fig 2). Sixteen additional patients started treat-
ment based on chest radiograph findings. Stratifying by type of health facility attended, 245/
267 (91.8%) submitted sputum among those attending the urban facility and 45/143 (31.5%)
among those attending rural health facilities (Fig 2).
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Time to submitting sputum among rural and urban health facility
attendees
In Kaplan-Meier analysis, there was strong evidence for a difference in time to submitting spu-
tum by location of health facility, where urban facility attendees submitted sputum earlier than
rural facility attendees (P<0.001) (Fig 3). Of urban facility attendees, 229 (80.4%) submitted
sputum on the day the test was requested, 10 (3.5%) submitted within 7 days and 6 (2.1%) after
14 days. However, among rural facility attendees, only 6 (4.2%) submitted sputum on the day
the test was requested, 18 (12.6%) within 7 days and 21 (14.7%) after 14 days (Fig 3).
Reasons for not submitting sputum
The main reasons given by participants for not submitting sputum were being too busy to go
to the laboratory (58/116, 50.0%), feeling well so not seeing the need to do the test (19, 16.4%),
having no money to travel to do the test (17, 14.7%) and being unable to produce sputum (15,
12.9%).
Association between type of health facility attended and submitting
sputum
In causal analysis, participants recruited from the urban health facility had a much higher odds
(unadjusted odds ratio [OR] 24.24, 95% CI 13.84–42.51) of submitting sputum compared to
those recruited at a rural health facility. Adjusting for distance from participants’ residence to
the laboratory resulted in the biggest reduction in the odds of submitting sputum, comparing
Fig 1. Flowchart of study recruitment and follow up of people requested to give sputum for TB investigation in Ketu South Municipality, Ghana.
https://doi.org/10.1371/journal.pone.0230604.g001
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urban and rural facility attendees (adjusted OR [aOR] 12.98, 95% CI 5.95–28.30) (Table 2).
After adjusting for all other confounders, in the final adjusted model, a strong association
between attending the urban versus rural health facilities and submitting sputum remained
(aOR 9.52, 95% CI 3.87–23.40) (Table 2).
Factors associated with submitting sputum among study participants
attending an urban or rural health facility
In univariable analysis (Table 3), rural versus urban residence (OR 0.08, 95% CI 0.05–0.15);
longer travel distance to the laboratory (OR 0.06, 95% CI 0.03–0.11 for 10–20 km and OR 0.17,
95% CI 0.07–0.41 for>20 km versus<10 km); and high versus low perception of TB-related
stigma (OR 0.39, 95% CI 0.24–0.62) were associated with a lower odds of submitting sputum.
Prior TB treatment (OR 4.00, 95%CI 1.19–13.460); more reported symptoms (OR 2.87, 95%
CI 1.47–5.59 for>4 versus 1–2), longer symptom duration (OR 2.20, 95% CI 1.39–3.50 for
>14 versus�14 days); and visit to at least one care providers prior to current clinic visit (OR
3.18, 95% CI 1.88–5.10) were predictors of submitting sputum.
Table 1. Baseline characteristics of participants (people requested to give sputum for TB investigation) in Ketu South Municipality, Ghana.
Characteristics Variable Urban health facility, n = 285 Rural health facility, n = 143 Total, N = 428 P-value
n (%) n (%) n (%)
Age (years) Mean ± SD 47.6±17.9 48.4±20.4 47.9±18.8 0.901
Gender Male 99 (34.7) 41 (28.7) 140 (32.7) 0.207
Female 186 (65.3) 102 (71.3) 288 (67.3)
Educational level No formal education 70 (24.6) 34 (23.8) 104 (24.3) 0.982
Primary/JHS 157 (55.1) 80 (55.9) 237 (55.4)
Secondary/Tertiary 58 (20.4) 29 (20.3) 87 (20.3)
Place of residence Urban 205 (71.9) 1 (0.7) 206 (48.1) <0.001
Rural 80 (28.1) 142 (99.3) 222 (51.9)
Distance to laboratory (km) Median (IQR) 2.6 (1.3–10.0) 17.3 (16.7–19.4) 10.0 (1.6–17.3) <0.001
Socioeconomic status (tertiles) High 114 (40.0) 28 (19.6) 142 (33.2) <0.001
Middle 86 (30.2) 57 (39.9) 143 (33.4)
Low 85 (29.8) 58 (40.6) 143 (33.4)
TB symptoms (yes) Cough 279 (97.9) 142 (99.3) 421 (98.4) 0.279
Fever 204 (71.6) 115 (80.4) 319 (74.5) 0.048
Night sweat 70 (24.6) 24 (16.8) 94 (22.0) 0.067
Weight loss 79 (27.7) 22 (15.4) 101 (23.6) 0.005
Symptoms duration (days) Median (IQR) 19 (7–31) 7 (7–14) 14 (7–28) <0.001
HIV status Positive 32 (11.2) 0 (0.0) 32 (7.5) <0.001
Negative 72 (25.3) 17 (11.9) 89 (20.8)
Don’t know 181 (63.5) 126 (88.1) 307 (71.7)
Diabetes No 273 (95.8) 142 (99.3) 415 (97.0) 0.046
Yes 12 (4.2) 1 (0.7) 13 (3.0)
BMI (kg/m2) Median (IQR) 24.6 (19.7–34.1) 25.1 (22.0–30.3) 24.8 (20.3–32.6) 0.077
Severity of illness (Karnofsky score) Mean ± SD 81.2±10.8 86.1±6.4 82.9±9.8 <0.001
Stigma Low perceived stigma 138 (48.4) 35 (24.5) 173 (40.4) <0.001
High perceived stigma 147 (51.6) 108 (75.5) 255 (59.6)
N = total number, n = number within facility, SD = standard deviation, IQR = interquartile range, BMI = body mass index, TB = tuberculosis, HIV = human
immunodeficiency virus, JHS (13–15 years) = junior high school
https://doi.org/10.1371/journal.pone.0230604.t001
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In predictive multivariable analysis, longer travel distance to the laboratory and high per-
ception of TB-related stigma remained associated with a lower odds of submitting sputum
(Table 3).
Discussion
In south-east Ghana, more than a quarter of presumptive TB patients never submitted a spu-
tum, and non-submission of sputum was most strongly associated with longer distance to the
laboratory. Studies from Zimbabwe, India and Tanzania have also reported high pre-diagnosis
loss-to-follow, 25%, 30.4% and 44% respectively [16–18], and some studies, including one
from Ghana, showed that attending rural health clinics and long travel distance were risk fac-
tors for delay or pre-diagnosis loss to follow-up [7, 10, 17, 19]. In contrast, pre-diagnosis attri-
tion was lower in South Africa and China (5% and 11% respectively) [20, 21], perhaps because
in South Africa, sputum specimens are transported free to a central laboratory for diagnosis.
TB-related stigma was independently associated with non-submission of sputum, consis-
tent with findings from a study in India [22]. Several studies have reported high perception of
TB-associated stigma [23–27], and specific actions are needed to counter this [28, 29].
An encouraging finding was that all patients with a positive TB result on their sputum were
promptly put on treatment. This contrasts with a study of routine data from a regional hospital
Fig 2. Cascade of TB care among people requested to give sputum for TB investigation in Ketu South Municipality, Ghana.
https://doi.org/10.1371/journal.pone.0230604.g002
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in Ghana in 2011 where pre-treatment loss-to-follow up was 38% [30], and a systematic review
which found an 18% pre-treatment loss to follow-up in Africa [31]. The difference could be
due to the presence of a “task-shifting officer”, dedicated to TB screening and follow-up in our
study hospital’s main outpatient department, supporting the value of this role.
Fig 3. Time from test request to submitting sputum for people requested to give sputum for TB investigation in Ketu South Municipality, Ghana.
https://doi.org/10.1371/journal.pone.0230604.g003
Table 2. Causal analysis showing association between the type of health facility attended and submitting a sputum
for a TB test, Ketu South Municipal—Ghana.
Association between type of health facility attended and submitting sputum OR CI P
Univariable+ 24.25 13.84–42.51 P<0.001
Confounder adjustment
Adjusted for longer distance from residence to laboratory 12.98 5.95–28.30 P<0.001
Adjusted for rural residence 18.25 8.08–41.21 P<0.001
Adjusted for negative HIV status 22.07 12.35–39.44 P<0.001
Adjusted for high perceived stigma 22.46 12.73–39.61 P<0.001
Adjusted for increasing number of symptoms 22.64 12.85–39.88 P<0.001
Final: adjusted for all of above 9.52 3.87–23.40 P<0.001
†bivariate analysis between type of health facility (rural or urban) and sputum submission as an outcome.
OR = odds ratio, CI = 95% confidence interval, P = p-value
https://doi.org/10.1371/journal.pone.0230604.t002
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Table 3. Factors associated with submitting sputum among study participants attending rural and urban health facilities in Ketu South Municipality, Ghana.
N = 410
Variable Number submitting sputum (%) OR (95% CI) P aOR (95%CI) P
Age group (years) �0.689
18–38 99/145 (68.3) 1
39–59 107/150 (71.3) 1.15 (0.70–1.90) 0.567
�60 84/115 (73.0) 1.26 (0.73–2.16) 0.403
Gender �0.177
Male 102/136 (75.0) 1 1
Female 188/274 (68.6) 0.73 (0.46–1.16) 0.182 0.90 (0.48–1.69) 0.739
Educational level �0.706
No formal education 65/96 (67.7) 1
Primary/JHS 162/228 (71.1) 1.17 (0.70–1.96) 0.549
Secondary/Tertiary 63/86 (73.3) 1.31 (0.69–2.48) 0.414
Place of residence �<0.001
Urban 182/197 (92.4) 1 1
Rural 108/213 (50.7) 0.08 (0.05-.015) <0.001 0.41 (0.16–1.03) 0.058
Distance to laboratory (Km) �<0.001
<10 184/197 (93.4) 1 1
10–20 74/168 (44.1) 0.06 (0.03–0.11) <0.001 0.12 (0.05–0.33) <0.001
>20 32/45 (71.1) 0.17 (0.07–0.41) <0.001 0.29 (0.10–0.86) 0.025
Socioeconomic status (tertiles) �0.002
Low 92/134 (68.7) 1 1
Middle 86/138 (62.3) 0.76 (0.46–1.25) 0.272 0.59 (0.30–1.13) 0.113
High 112/138 (81.2) 1.97 (1.12–3.45) 0.018 1.03 (0.47–2.24) 0.945
Ever treated for TB �0.008
No 263/380 (69.2) 1 1
Yes 27/30 (90.0) 4.00 (1.19–13.46) 0.025 2.02 (0.45–9.07) 0.359
Number of symptoms �<0.001
1–2 34/56 (60.7) 1 1
3–4 123/191 (64.4) 1.17 (0.63–2.16) 0.615 1.33 (0.60–2.96) 0.488
>4 133/163 (81.6) 2.87 (1.47–5.59) 0.002 2.00 (0.83–4.80) 0.12
Duration of symptoms (days) �<0.001
�14 158/245 (64.5) 1 1
>14 132/165 (80.0) 2.20 (1.39–3.50) 0.001 0.83 (0.43–1.62) 0.589
HIV status �0.037
Positive 28/28 (100.0) 1 1
Negative 66/85 (77.7) 1.79 (1.02–3.15) 0.043 0.85 (0.40–1.83) 0.678
Don’t know+ 196/297 (66.0) - - - -
Severity of illness (Karnofsky score) �0.024
Less severe (�90) 136/217 (62.7) 1 1
Moderately severe (70–80) 133/167 (79.6) 2.70 (1.24–5.92) 0.013 1.84 (0.68–4.98) 0.228
Severe (�60) 21/26 (80.8) 0.92 (0.17–5.10) 0.924 0.14 (0.01–2.28) 0.165
Number of previous care providers visited �<0.001
0 173/272 (63.6) 1 1
�1 117/138 (84.8) 3.18 (1.88–5.40) <0.001 2.05 (1.02–4.13) 0.045
Stigma �<0.001
Low perception 134/164 (81.7) 1 1
(Continued)
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Mortality among study participants was high, with 3% documented to have died within two
months of enrolment, which is high for a population of presumptive TB patients but supports
data from Zimbabwe [32]. An additional, 4% of participants recruited were lost to follow-up, if
all these had died, two-month mortality would have been 7%. This further emphasizes the
need for better access to prompt diagnosis and treatment for TB and other conditions.
Findings from this study have both programmatic and health system implications. This
study clearly shows there is a gap in the cascade between a sputum test being requested and
sputum being submitted, particularly among persons attending rural health facilities, and this
can be attributed to the distance people need to travel to submit a sputum. An effective speci-
men transport system might bridge the gap in the diagnostic cascade.
Limitations
The study was designed to be observational rather than interventional and so the follow-up
calls aimed to find out whether the participant had given a specimen and/or started TB treat-
ment rather than motivating them to give a specimen; however, follow-up calls could have
prompted some participants to give a sputum specimen, and thus we may have underesti-
mated the true pre-diagnostic delays or losses.
Strengths
The prospective cohort design of our study allowed us to determine pre-diagnostic losses
directly and explore the reasons for losses, whereas previous studies have been based on sec-
ondary data analysis, or recruited patients already on TB treatment, thus excluding those who
never started treatment.
Conclusion
Almost 30% of patients asked to give a sputum specimen for TB testing in Ketu South munici-
pality, Ghana, did not submit sputum: this was primarily determined by longer distance to the
TB diagnostic laboratory. Closing this gap in the TB diagnostic cascade is an important step in
reducing treatment delay and reducing TB transmission.
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Table 3. (Continued)
N = 410
Variable Number submitting sputum (%) OR (95% CI) P aOR (95%CI) P
High perception 156/246 (63.4) 0.39 (0.24–0.62) <0.001 0.54 (0.30–0.98) 0.043
�Log likelihood P-value,
+Omitted from model due to collinearity,
OR = odds ratio, aOR = adjusted odds ratio, P = p-value, JHS (13–15 years) = Junior high school
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